Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 241479-67-4 | Product Number: I1188
Isavuconazole
Purity: >98.0%(HPLC)(qNMR)
Synonyms:
- 4-[2-[(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]thiazol-4-yl]benzonitrile
- (2R,3R)-3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
Product Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
250MG |
€ 178,00
|
2 | 23 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | I1188 |
Purity / Analysis Method | >98.0%(HPLC)(qNMR) |
Molecular Formula / Molecular Weight | C__2__2H__1__7F__2N__5OS = 437.47 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
Packaging and Container | 250MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 241479-67-4 |
Reaxys Registry Number | 9295730 |
MDL Number | MFCD06407745 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(qNMR) | min. 98.0 % |
Melting point | 128.0 to 132.0 °C |
Specific rotation | -60.0 to -66.0 deg(C=0.6, CHCl3) |
NMR | confirm to structure |
Properties (reference)
Melting Point | 130 °C |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P261 : Avoid breathing dust. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. |
Related Laws:
RTECS# | DI3950800 |
Transport Information:
HS Number | 2934100090 |
Application
Isavuconazole: A Broad-Spectrum Triazole Antifungal Agent
Isavuconazole (BAL4815) is a broad-spectrum triazole antifungal agent, and has shown in vitro activity against a large number of important yeasts and fungi including Aspergillus and Candida species. It inhibits the synthesis of ergosterol, a key component of the fungal cell membrane, through the inhibition of cytochrome P-450 dependent enzyme lanosterol 14-α-demethylase (P45014DM). (The product is for research purpose only.)
References
- In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species
- Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole
- Isavuconazole: a new broad-spectrum triazole antifungal agent (a review)
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.